1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NOVO NORDISK - ADR

Novo Nordisk - ADR

XNYS: NVO

Expensive Underperformer
Download real time

73.60 -1.73 (-2.30%)

New 52W Low today

8.1M XNYS Volume

XNYS 25 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
290,403

Operating Revenue TTM

High in industry
100,988

Net profit TTM

Market Runner Up
34.8

Net Profit Margin TTM %

25

Operating Revenue growth TTM %

Below industry Median
20.7

Net Profit TTM Growth %

Below industry Median
Inks Deal
Novo Nordisk secures global rights to develop and sell United Labs' weight loss drug for $2 billion See details

Novo Nordisk - ADR quarterly, annual results, revenue, profit, P&L, Balance Sheet, Cash Flow, Annual Reports, Margins - 15 Years history